期刊
MOLECULAR NEUROBIOLOGY
卷 55, 期 7, 页码 6050-6062出版社
SPRINGER
DOI: 10.1007/s12035-017-0823-9
关键词
Glycogen synthase kinases-3; Mammalian target of rapamycin; Neurons; Neuronal survival; Excitotoxicity
资金
- Polish National Science Centre [2011/01/N/NZ3/05409, 2011/01/M/NZ3/05413, 2011/01/B/NZ3/05397, 2012/05/B/NZ3/00429, 2013/11/D/NZ3/01079, 2013/09/N/NZ3/01249]
- FP7 European Union [223276]
- European Union funds from the European Social Fund
- IUVENTUS [IP2012 037872]
- 7FP grants [223276, 602391]
- Polish Ministerial funds for science
- Foundation for Polish Science [MPD/2009/4]
- L'Oreal-UNESCO
- Foundation for Polish Science
- FP7 grant [229676]
Glycogen synthase kinases-3 beta (GSK3 beta) is a key regulator of cell homeostasis. In neurons, GSK3 beta contributes to control of neuronal transmission and plasticity. Despite extensive studies in non-neuronal cells, crosstalk between GSK3 beta and other signaling pathways remains not well defined in neurons. In the present study, we report that GSK3 beta positively affected the activity of effectors of mammalian target of rapamycin complex 1 (mTORC1) and complex 2 (mTORC2), in mature neurons in vitro and in vivo. GSK3 beta also promoted prosurvival signaling and attenuated kainic acid-induced apoptosis. Our study identified GSK3 beta as a positive regulator of prosurvival signaling, including the mTOR pathway, and indicates the possible neuroprotective role of GSK3 beta in models of pharmacologically induced excitotoxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据